Growth Metrics

Ekso Bionics Holdings (EKSO) Non-Current Deffered Revenue (2016 - 2026)

Ekso Bionics Holdings has reported Non-Current Deffered Revenue over the past 13 years, most recently at $1.4 million for Q4 2025.

  • On a quarterly basis, Non-Current Deffered Revenue fell 26.35% to $1.4 million in Q4 2025 year-over-year; TTM through Dec 2025 was $1.4 million, a 26.35% decrease, with the full-year FY2025 number at $1.4 million, down 26.35% from a year prior.
  • Non-Current Deffered Revenue reached $1.4 million in Q4 2025 per EKSO's latest filing, down from $1.6 million in the prior quarter.
  • The five-year high for Non-Current Deffered Revenue was $2.2 million in Q4 2023, with the low at $1.0 million in Q3 2022.
  • The 5-year median for Non-Current Deffered Revenue is $1.6 million (2023), against an average of $1.6 million.
  • Peak YoY movement for Non-Current Deffered Revenue: crashed 34.18% in 2022, then soared 110.17% in 2023.
  • Tracing EKSO's Non-Current Deffered Revenue over 5 years: stood at $1.5 million in 2021, then plummeted by 30.03% to $1.0 million in 2022, then soared by 110.17% to $2.2 million in 2023, then dropped by 11.48% to $1.9 million in 2024, then decreased by 26.35% to $1.4 million in 2025.
  • According to Business Quant data, Non-Current Deffered Revenue over the past three periods came in at $1.4 million, $1.6 million, and $1.7 million for Q4 2025, Q3 2025, and Q2 2025 respectively.